Publications scientifiques Bordet

Publications scientifiques Bordet

  • Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study.

  • Auteurs Van Baelen K, Nguyen HL, Richard F, Zels G, Karsten MM, Nader-Marta G, Vermeulen P, Dirix L, Dordevic AD, de Azambuja E, Larsimont D, Maetens M, Biganzoli E, Wildiers H, Smeets A, Nevelsteen I, Neven P, Floris G, Desmedt C
  • Auteurs (entité) NADER MARTA GUILHERME
  • Revue Breast Cancer Res
  • Date de publication 2025-06
Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study.
  • Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study.

  • Auteurs Maertens JA, Thompson GR, Spec A, Donovan FM, Hammond SP, Bruns AHW, Rahav G, Shoham S, Johnson R, Rijnders B, Schaenman J, Hoenigl M, Morrissey CO, Mehta SR, Heath CH, Koehler P, Paterson DL, Slavin MA, Fortún J, Nguyen MH, Patterson TF, Uspenskaya O, Van de Veerdonk FL, Verweij PE, Aoun M, Georgala A, Alexander BD, Chayakulkeeree M, Mehra V, Miceli MH, Sikka MK, Solé A, Walsh TJ, Aguado JM, Holland SM, Moussa M, Rautemaa-Richardson R, Bazaz R, Schwartz S, Walsh SR, Plate M, Yehudai-Ofir D, Brüggemann RJ, Cornely OA, Ostrosky-Zeichner L, Vazquez JA, White PL, Cornelissen K, Ross GG, Fitton L, Dane A, Zinzi D, Rex JH, Chen SC
  • Auteurs (entité) GEORGALA ASPASIA
  • Revue Lancet Infect Dis
  • Date de publication 2025-06
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study.
  • Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study.

  • Auteurs Maertens JA, Thompson GR, Spec A, Donovan FM, Hammond SP, Bruns AHW, Rahav G, Shoham S, Johnson R, Rijnders B, Schaenman J, Hoenigl M, Morrissey CO, Mehta SR, Heath CH, Koehler P, Paterson DL, Slavin MA, Fortún J, Nguyen MH, Patterson TF, Uspenskaya O, Van de Veerdonk FL, Verweij PE, Aoun M, Georgala A, Alexander BD, Chayakulkeeree M, Mehra V, Miceli MH, Sikka MK, Solé A, Walsh TJ, Aguado JM, Holland SM, Moussa M, Rautemaa-Richardson R, Bazaz R, Schwartz S, Walsh SR, Plate M, Yehudai-Ofir D, Brüggemann RJ, Cornely OA, Ostrosky-Zeichner L, Vazquez JA, White PL, Cornelissen K, Ross GG, Fitton L, Dane A, Zinzi D, Rex JH, Chen SC
  • Auteurs (entité) AOUN MICKAEL
  • Revue Lancet Infect Dis
  • Date de publication 2025-06
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study.
  • Comprehensive profiling of the mutational landscape of hidradenoma papilliferum validates key role of alterations in the PI3K/AKT pathway.

  • Auteurs Cheema S, van der Weyden L, Wong K, Del Castillo Velasco-Herrera M, Billington J, Vermes I, Anderson E, Allen L, de Saint Aubain N, van der Horst MPJ, Alomari AK, Mogler C, Monteagudo C, Frew D, Billings SD, Arends MJ, Ferreira I, Brenn T, Adams DJ
  • Auteurs (entité) DE SAINT AUBAIN NICOLAS
  • Revue Br J Dermatol
  • Date de publication 2025-06
Comprehensive profiling of the mutational landscape of hidradenoma papilliferum validates key role of alterations in the PI3K/AKT pathway.
  • Q-TWiST Analysis to Assess Benefit-Risk of Sacituzumab Govitecan in Previously Treated Patients With Metastatic Triple-Negative Breast Cancer.

  • Auteurs Bardia A, Rugo HS, Sedrak MS, Loibl S, Tolaney SM, Punie K, Hurvitz SA, Kalinsky KM, Cortés J, O'Shaughnessy JA, Dieras V, Piccart-Gebhart MJ, Dasgupta A, Kaushik A, Lai C, Shi L, Brufsky A
  • Auteurs (entité) PICCART MARTINE
  • Revue JCO Oncol Pract
  • Date de publication 2025-06
Q-TWiST Analysis to Assess Benefit-Risk of Sacituzumab Govitecan in Previously Treated Patients With Metastatic Triple-Negative Breast Cancer.
  • Rotifers in space: transcriptomic response of the bdelloid rotifer Adineta vaga aboard the International Space Station.

  • Auteurs Moris VC, Bruneau L, Berthe J, Coos R, Baselet B, Heuskin AC, Caplin N, Demets R, Krause J, Zuijderduijn L, Tortora A, Herova M, Penninckx S, Parmitano L, Tabury K, Baatout S, Van Doninck K, Hespeels B
  • Auteurs (entité) Penninckx Sébastien
  • Revue BMC Biol
  • Date de publication 2025-07
Rotifers in space: transcriptomic response of the bdelloid rotifer Adineta vaga aboard the International Space Station.
Erasme hospital

Hôpital Erasme

Consultez toutes les publications scientifiques d'Erasmus

Huderf hospital

Hôpital pédiatrique Reine Fabiola

Consultez toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola

Bordet hospital

Institut Jules Bordet

Consultez toutes les publications scientifiques de Jules Bordet